Radiopharma dose varies globally for pediatric exams

April 7, 2016

 While there are guidelines for recommended radiopharmaceutical doses for pediatric nuclear medicine patients, there is still wide variability around the world in terms of how those standards are followed, according to a new report published online March 31 in the Journal of Nuclear Medicine.

Nuclear medicine practices located in regions with such recommendations for certain procedures, such as North American, Europe, and Japan, tend to closely comply with those guidelines, "although some wide variations still exist," concluded the Nuclear Medicine Global Initiative.

That lack of compliance, even in a few cases, can lead to the risk of a potential adverse event from ionizing radiation at certain dose levels.

Previous surveys have found that nuclear medicine practitioners who know about standards for dose administration tend to follow them "reasonably consistently," said lead author Fred Fahey, DSc, director of physics in nuclear medicine and molecular imaging at Boston Children's Hospital. "But many people don't know the standards exist," he told "If we can get the other developing countries and nuclear medicine practitioners in those countries to be aware of these guidelines, then I think we have a chance to make sure the right dose is being used at the right time."

Read the full article.